Tissue Regenix Group PLC Holding(s) in Company (5139J)
June 12 2014 - 10:46AM
UK Regulatory
TIDMTRX
RNS Number : 5139J
Tissue Regenix Group PLC
12 June 2014
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------------
1. Identity of the issuer or Tissue Regenix Group Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
---------------------------------------------------------- --------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------- -------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------- -------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------- -------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------- -------------------------
Other (please
specify):
---------------------------------------------------------- -------------------------
3. Full name of person(s) Baillie Gifford & Co
subject to the
notification obligation:
(iii)
---------------------------------------------------------- --------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
---------------------------------------------------------- --------------------------
5. Date of the transaction 11 June 2014
and date on
which the threshold is
crossed or
reached: (v)
---------------------------------------------------------- --------------------------
6. Date on which issuer 12 June 2014
notified:
---------------------------------------------------------- --------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 5%
---------------------------------------------------------- --------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- --------- ------------ ------------ -----------
Ordinary
Share Below Below
GB00B5SGVL29 5% 5% 36870574 36870574 5.64%
---------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
N/A
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- ---------------- ------------------------- -----------------------
N/A Nominal Delta
---------------- -------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
36870574 5.64%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------
In the narrative below, the figures in [ ] indicate
the amount of voting rights and the percentage held
by each controlled undertaking where relevant.
Baillie Gifford & Co, a discretionary investment manager,
is the parent undertaking of an investment management
group.
Its wholly-owned subsidiary undertaking Baillie Gifford
Overseas Limited [14,600,000; 2.23%] is also a discretionary
investment manager.
Its wholly-owned subsidiary undertaking Baillie Gifford
& Co Limited [13,655,000; 2.09%] is an OEIC Authorised
Corporate Director and Unit Trust Manager which has
delegated its discretionary investment management role
to Baillie Gifford & Co.
Proxy Voting:
--------------------------------------------------------------------------
10. Name of the proxy holder: N/A
---------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
---------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
---------------------------------------------------------- --------------
13. Additional information:
---------------------------------------------------------- --------------
14. Contact name: Paul Salmond
---------------------------------------------------------- --------------
15. Contact telephone number: 0131 275 3169
---------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUASRSNANAAR
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Sep 2023 to Sep 2024